Advisory Board
 
 
 
John D. Diekman, Ph.D.

John D. Diekman, Ph.D.

Founder and Managing Partner
5AM Ventures


John D. Diekman, Ph.D. is a founder and Managing Partner of 5AM Ventures. Prior to founding 5AM, Dr. Diekman was a founder and Managing Director of Bay City Capital, a life sciences investment firm. Previously, Dr. Diekman was Chairman and CEO of Affymetrix, Inc. where he still serves as a Director. Dr. Diekman currently serves as Board Chairman of Ambrx and Envoy Therapeutics as well as on the Boards of Directors of Igenica, Ingenuity Systems, Marcadia, PhaseRx and Wildcat Discovery. He is a Special Advisor to the Singapore Economic Development Board. He is a Trustee of Princeton University and is also former Trustee of The California Institute of Technology and The Scripps Research Institute, where he served as Chairman. He is an Honorary Officer in the Order of Australia. Dr. Diekman received a B.A. in Chemistry from Princeton University and a Ph.D. in Chemistry from Stanford University. Dr. Diekman holds an Honorary Degree of Doctor of Laws from Monash University. Dr. Diekman is based in the Menlo Park, CA office.